Does TOFACITINIB Cause Treatment failure? 5,116 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 5,116 reports of Treatment failure have been filed in association with TOFACITINIB (XELJANZ XR). This represents 3.3% of all adverse event reports for TOFACITINIB.
5,116
Reports of Treatment failure with TOFACITINIB
3.3%
of all TOFACITINIB reports
1,011
Deaths
1,660
Hospitalizations
How Dangerous Is Treatment failure From TOFACITINIB?
Of the 5,116 reports, 1,011 (19.8%) resulted in death, 1,660 (32.4%) required hospitalization, and 1,247 (24.4%) were considered life-threatening.
Is Treatment failure Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 5,116 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Treatment failure?
METHOTREXATE (14,672)
ETANERCEPT (11,893)
ADALIMUMAB (9,990)
ABATACEPT (9,301)
RITUXIMAB (9,217)
TOCILIZUMAB (9,097)
HYDROXYCHLOROQUINE (8,786)
LEFLUNOMIDE (8,686)
INFLIXIMAB (8,535)
SULFASALAZINE (7,423)
Which TOFACITINIB Alternatives Have Lower Treatment failure Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN